Analysis

Micro-machines: nanotech offers new possibilities for disease detection and drug delivery

Micro-machines: nanotech offers new possibilities for disease detection and drug delivery

Pharma Technology Focus – Issue 59

Pharma Technology Focus – Issue 59

Challenging the link between pharma innovation and US drug pricing

Challenging the link between pharma innovation and US drug pricing

Pharma Technology Focus – Issue 58

Pharma Technology Focus – Issue 58

Cancergraph: a desperately needed link between patient and clinical trial

Cancergraph: a desperately needed link between patient and clinical trial

Pharma Technology Focus – Issue 57

Pharma Technology Focus – Issue 57

Turning to turmeric: exciting drug candidate or another dead end?

Turning to turmeric: exciting drug candidate or another dead end?

Learning from tragedy: safety and dosing in first-in-human trials

Learning from tragedy: safety and dosing in first-in-human trials

Using shark antibodies to treat Alzheimer’s disease

Using shark antibodies to treat Alzheimer’s disease

Moving mountains: balancing safety and speed in drug development

Moving mountains: balancing safety and speed in drug development

How an Alzheimer’s drug turned tooth regenerator could unlock regenerative medicine

How an Alzheimer’s drug turned tooth regenerator could unlock regenerative medicine

Nigeria’s HIV ‘breakthrough’: separating truth from hope

Nigeria’s HIV ‘breakthrough’: separating truth from hope

Pharma Technology Focus – Issue 56

Pharma Technology Focus – Issue 56

Why the UK NHS needs clinical research

Why the UK NHS needs clinical research

Pharma payments to doctors: seeking transparency

Pharma payments to doctors: seeking transparency

How does the NHS weigh the costs of HIV preventing drugs?

How does the NHS weigh the costs of HIV preventing drugs?

Pharma Technology Focus – Issue 54

Pharma Technology Focus – Issue 54

Debating the value of targeted lung cancer treatments

Debating the value of targeted lung cancer treatments

Tackling false trial data in China

Tackling false trial data in China

Ketamine: taking aim at depression

Ketamine: taking aim at depression

Pharma Technology Focus – Issue 53

Pharma Technology Focus – Issue 53
cachename:Featurescachekey:rd-137342983_1031809799_rd-1665407042_727740091_rd-488908060_1460672566_ap1460672566_727740091_1492331643